Abingdon Health PLC
LSE:ABDX

Watchlist Manager
Abingdon Health PLC Logo
Abingdon Health PLC
LSE:ABDX
Watchlist
Price: 6 GBX Market Closed
Market Cap: £15.1m

Relative Value

ABDX doesn't have a meaningful market cap.

The Relative Value of one ABDX stock under the Base Case scenario is hidden GBX. Compared to the current market price of 6 GBX, Abingdon Health PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ABDX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

ABDX Competitors Multiples
Abingdon Health PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Abingdon Health PLC
LSE:ABDX
15.1m GBP 1.8 -4.4 -4.6 -3.8
JP
Hoya Corp
TSE:7741
8.8T JPY 9.9 42.1 26.1 31.3
CH
Alcon AG
SIX:ALC
30.9B CHF 3.9 38.1 19.9 38.7
US
Medline Inc
NASDAQ:MDLN
35.5B USD 0 0 0 0
DK
Coloplast A/S
CSE:COLO B
122.3B DKK 4.4 33.6 15.5 18.4
US
Align Technology Inc
NASDAQ:ALGN
11.7B USD 2.9 30.9 14 17.8
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP 2.7 29.4 17.7 28.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.9B CNY 9.4 25.9 23.3 23.3
KR
HLB Inc
KOSDAQ:028300
7.3T KRW 83.6 -30.7 -76.7 -72.6
CA
Bausch + Lomb Corp
NYSE:BLCO
5.9B USD 1.2 -19.4 19.4 91.5
CH
Ypsomed Holding AG
SIX:YPSN
4.2B CHF 5.3 21.7 14.1 19.1
P/E Multiple
Earnings Growth PEG
UK
Abingdon Health PLC
LSE:ABDX
Average P/E: 31.7
Negative Multiple: -4.4
N/A N/A
JP
Hoya Corp
TSE:7741
42.1
13%
3.2
CH
Alcon AG
SIX:ALC
38.1
25%
1.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
33.6
22%
1.5
US
Align Technology Inc
NASDAQ:ALGN
30.9
27%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
29.4
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25.9
9%
2.9
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -30.7 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.4 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
21.7
32%
0.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Abingdon Health PLC
LSE:ABDX
Average EV/EBITDA: 18.7
Negative Multiple: -4.6
N/A N/A
JP
Hoya Corp
TSE:7741
26.1
11%
2.4
CH
Alcon AG
SIX:ALC
19.9
8%
2.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
15.5
8%
1.9
US
Align Technology Inc
NASDAQ:ALGN
14
13%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
17.7
10%
1.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.3
15%
1.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -76.7 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
19.4
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
14.1
21%
0.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Abingdon Health PLC
LSE:ABDX
Average EV/EBIT: 33.6
Negative Multiple: -3.8
N/A N/A
JP
Hoya Corp
TSE:7741
31.3
N/A N/A
CH
Alcon AG
SIX:ALC
38.7
23%
1.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
18.4
8%
2.3
US
Align Technology Inc
NASDAQ:ALGN
17.8
16%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
28.8
22%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.3
11%
2.1
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -72.6 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
91.5
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
19.1
29%
0.7